Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease

Ivan R. Schwab, Merle Reyes, Roslyn Rivkah Isseroff

Research output: Contribution to journalArticle

321 Citations (Scopus)

Abstract

Purpose. To bioengineer a corneal surface replacement using ex vivo expanded, cultured corneal epithelial stem cells seeded on a matrix derived from amniotic membrane and use this bioengineered graft to manage difficult ocular surface disease. Methods. Fourteen patients with ocular surface disease unresponsive to standard medical and surgical treatments, including seven patients with presumed limbal stem cell deficiency were chosen for transplantation of a bioengineered composite corneal surface in eye each. Presumed corneal stem cells were harvested from either the patient's or related donor's limbus, expanded ex vivo, and cultivated on a carrier of modified human amniotic membrane. The resulting composite cultured tissue was transplanted to the ocular surface of the diseased eye, from which the abnormal tissue had been surgically removed. Ten patients received autologous grafts, and four received allogeneic grafts. Results. A successful outcome, defined as restoration or improvement of vision, along with maintenance of corneal re-epithelialization and absence or recurrence of surface disease was obtained in 6 of the 10 patients with autologous procedures and in all 4 allogeneic transplants. Follow-up ranged 6-19 months with a mean of 13 months. Conclusions. This novel technique documents that presumed corneal epithelial stem cells can be harvested safely from the limbus, expanded successfully in vitro, and grown on denuded amniotic membrane. The resultant composite cultured tissue can be transplanted and appears to successfully manage eyes with difficult ocular surface disease, including those with stem cell deficiency. This technique minimizes the threat of damage or depletion to the contralateral or donor limbus.

Original languageEnglish (US)
Pages (from-to)421-426
Number of pages6
JournalCornea
Volume19
Issue number4
DOIs
StatePublished - Jul 2000

Fingerprint

Tissue Transplantation
Eye Diseases
Stem Cells
Amnion
Transplants
Epithelial Cells
Tissue Donors
Re-Epithelialization
Transplantation
Maintenance
Recurrence

Keywords

  • Amniotic membrane
  • Corneal epithelium
  • Corneal stem cells
  • Cultured grafts
  • Human cornea
  • Limbus
  • Stem cell
  • Tissue bioengineering

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease. / Schwab, Ivan R.; Reyes, Merle; Isseroff, Roslyn Rivkah.

In: Cornea, Vol. 19, No. 4, 07.2000, p. 421-426.

Research output: Contribution to journalArticle

@article{657ac3bd48fe40888c7facd4eb03c817,
title = "Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease",
abstract = "Purpose. To bioengineer a corneal surface replacement using ex vivo expanded, cultured corneal epithelial stem cells seeded on a matrix derived from amniotic membrane and use this bioengineered graft to manage difficult ocular surface disease. Methods. Fourteen patients with ocular surface disease unresponsive to standard medical and surgical treatments, including seven patients with presumed limbal stem cell deficiency were chosen for transplantation of a bioengineered composite corneal surface in eye each. Presumed corneal stem cells were harvested from either the patient's or related donor's limbus, expanded ex vivo, and cultivated on a carrier of modified human amniotic membrane. The resulting composite cultured tissue was transplanted to the ocular surface of the diseased eye, from which the abnormal tissue had been surgically removed. Ten patients received autologous grafts, and four received allogeneic grafts. Results. A successful outcome, defined as restoration or improvement of vision, along with maintenance of corneal re-epithelialization and absence or recurrence of surface disease was obtained in 6 of the 10 patients with autologous procedures and in all 4 allogeneic transplants. Follow-up ranged 6-19 months with a mean of 13 months. Conclusions. This novel technique documents that presumed corneal epithelial stem cells can be harvested safely from the limbus, expanded successfully in vitro, and grown on denuded amniotic membrane. The resultant composite cultured tissue can be transplanted and appears to successfully manage eyes with difficult ocular surface disease, including those with stem cell deficiency. This technique minimizes the threat of damage or depletion to the contralateral or donor limbus.",
keywords = "Amniotic membrane, Corneal epithelium, Corneal stem cells, Cultured grafts, Human cornea, Limbus, Stem cell, Tissue bioengineering",
author = "Schwab, {Ivan R.} and Merle Reyes and Isseroff, {Roslyn Rivkah}",
year = "2000",
month = "7",
doi = "10.1097/00003226-200007000-00003",
language = "English (US)",
volume = "19",
pages = "421--426",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease

AU - Schwab, Ivan R.

AU - Reyes, Merle

AU - Isseroff, Roslyn Rivkah

PY - 2000/7

Y1 - 2000/7

N2 - Purpose. To bioengineer a corneal surface replacement using ex vivo expanded, cultured corneal epithelial stem cells seeded on a matrix derived from amniotic membrane and use this bioengineered graft to manage difficult ocular surface disease. Methods. Fourteen patients with ocular surface disease unresponsive to standard medical and surgical treatments, including seven patients with presumed limbal stem cell deficiency were chosen for transplantation of a bioengineered composite corneal surface in eye each. Presumed corneal stem cells were harvested from either the patient's or related donor's limbus, expanded ex vivo, and cultivated on a carrier of modified human amniotic membrane. The resulting composite cultured tissue was transplanted to the ocular surface of the diseased eye, from which the abnormal tissue had been surgically removed. Ten patients received autologous grafts, and four received allogeneic grafts. Results. A successful outcome, defined as restoration or improvement of vision, along with maintenance of corneal re-epithelialization and absence or recurrence of surface disease was obtained in 6 of the 10 patients with autologous procedures and in all 4 allogeneic transplants. Follow-up ranged 6-19 months with a mean of 13 months. Conclusions. This novel technique documents that presumed corneal epithelial stem cells can be harvested safely from the limbus, expanded successfully in vitro, and grown on denuded amniotic membrane. The resultant composite cultured tissue can be transplanted and appears to successfully manage eyes with difficult ocular surface disease, including those with stem cell deficiency. This technique minimizes the threat of damage or depletion to the contralateral or donor limbus.

AB - Purpose. To bioengineer a corneal surface replacement using ex vivo expanded, cultured corneal epithelial stem cells seeded on a matrix derived from amniotic membrane and use this bioengineered graft to manage difficult ocular surface disease. Methods. Fourteen patients with ocular surface disease unresponsive to standard medical and surgical treatments, including seven patients with presumed limbal stem cell deficiency were chosen for transplantation of a bioengineered composite corneal surface in eye each. Presumed corneal stem cells were harvested from either the patient's or related donor's limbus, expanded ex vivo, and cultivated on a carrier of modified human amniotic membrane. The resulting composite cultured tissue was transplanted to the ocular surface of the diseased eye, from which the abnormal tissue had been surgically removed. Ten patients received autologous grafts, and four received allogeneic grafts. Results. A successful outcome, defined as restoration or improvement of vision, along with maintenance of corneal re-epithelialization and absence or recurrence of surface disease was obtained in 6 of the 10 patients with autologous procedures and in all 4 allogeneic transplants. Follow-up ranged 6-19 months with a mean of 13 months. Conclusions. This novel technique documents that presumed corneal epithelial stem cells can be harvested safely from the limbus, expanded successfully in vitro, and grown on denuded amniotic membrane. The resultant composite cultured tissue can be transplanted and appears to successfully manage eyes with difficult ocular surface disease, including those with stem cell deficiency. This technique minimizes the threat of damage or depletion to the contralateral or donor limbus.

KW - Amniotic membrane

KW - Corneal epithelium

KW - Corneal stem cells

KW - Cultured grafts

KW - Human cornea

KW - Limbus

KW - Stem cell

KW - Tissue bioengineering

UR - http://www.scopus.com/inward/record.url?scp=0033911272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033911272&partnerID=8YFLogxK

U2 - 10.1097/00003226-200007000-00003

DO - 10.1097/00003226-200007000-00003

M3 - Article

C2 - 10928750

AN - SCOPUS:0033911272

VL - 19

SP - 421

EP - 426

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 4

ER -